Tag: SPL
Starpharma’s DEP irinotecan candidate has positive impact on human pancreatic cancer in mice
Starpharma (ASX: SPL) reported its DEP irinotecan candidate has induced “complete tumour regression” when trialled on mouse xenograft models with human pancreatic cancer.
During the...
Starpharma sells Agrochemicals business to Agrium for $35M
Starpharma Holdings (ASX: SPL) has completed a transaction to sell its agrochemicals and Priostar® business (Starpharma Agrochemicals) to Agrium, Inc. (NYSE: AGU, TSE: AGU)...